← FDA Drug Approvals (Drugs@FDA)

VASOPRESSIN IN SODIUM CHLORIDE 0.9%

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2023-09-29

Drug application

FDA Application #

NDA217569

Application type

New Drug Application

Brand name

VASOPRESSIN IN SODIUM CHLORIDE 0.9%

Generic name

VASOPRESSIN IN 0.9% SODIUM CHLORIDE

Active ingredients

VASOPRESSIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2023-09-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown